Information about the launch of generic Myrbetriq. Effective on the date of launch, Ap, generic Myrbetriq (mirabegron) is not covered on Humana's
FDA has granted some exclusivities to Cialis. Till the time these exclusivities are active, no other company can market a generic or bioequivalent version of Cialis, regardless of the status of it's patents. Cialis's generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be
Generic Release Date: Viagra's generic launch date based on the expiry of its last outstanding patent is estimated to be (This date is subject to change depending upon the
: Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years. Generic Release Date: Xarelto's generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be (This date is subject to change depending upon the
Cialis's generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be (This date is subject to change depending upon the patent
Generic Release Date: Stendra's generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application) Cialis Used for treating erectile
Generic Release Date: Cialis's generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be (This date is subject to change depending upon the patent filing activities by the drug owner or
It is protected by 3 US drug patents filed in 2025 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be . Generic Release Date: Viagra's generic launch date based on the expiry of its last outstanding patent is estimated to be (This date is subject to
Generic Release Date: Cialis's generic launch date based on the last expiry date of its patents and exclusivities combined is estimated to be (This date is subject to change depending upon the patent filing activities by the drug owner or
Comments